Financhill
Back

Surmodics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
35

SRDX
Surmodics

Last Price:
38.28
Seasonality Move:
5.04%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.37
Seasonality Move:
19.45%
Sell
35
Surmodics (SRDX) is a Sell

Is Surmodics a Buy, Sell or Hold?

  • The current Surmodics [SRDX] share price is $38.28. The Score for SRDX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • SRDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.39. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRDX Stock Price Chart

What is Surmodics's stock price today?

  • The Surmodics share price today is $38.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRDX is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

SRDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 40.91 Sell
Chaikin Money Flow: -39638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.26 - 39.04) Sell
Bollinger Bands (100): (39.03 - 41.89) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 43.35 Sell
Chaikin Money Flow: -59516 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.43 - 13.29) Sell
Bollinger Bands (100): (11.37 - 14.45) Sell

SRDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.45 Sell
20-day SMA: 38.49 Sell
50-day SMA: 39.12 Sell
200-day SMA: 35.78 Buy
8-day EMA: 38.4 Sell
20-day EMA: 38.58 Sell
50-day EMA: 39.02 Sell
200-day EMA: 36.84 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.69 Sell
20-day SMA: 12.8 Sell
50-day SMA: 13.82 Sell
200-day SMA: 12.31 Buy
8-day EMA: 12.69 Sell
20-day EMA: 12.96 Sell
50-day EMA: 13.27 Sell
200-day EMA: 11.76 Buy

Surmodics Earnings Growth & SRDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.31 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.

Surmodics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):